UPDATE : Wednesday, April 24, 2019
HanAll starts P3 clinical trials for dry eye treatment in US by Lee Han-soo 2019-03-12 10:41
Kolon gets FDA nod for testing gene therapy for neuropathic pain by Jeong Sae-im 2019-03-11 17:01
LSK Global PS sets up subsidiary by Lee Han-soo 2019-03-11 15:14
LG Chem to develop sextuple influenza vaccine by Lee Han-soo 2019-03-11 14:31
Jeil releases P3 clinical trial results for anti-hypertension treatment by Lee Han-soo 2019-03-11 14:03
Daewoong’s pulmonary fibrosis treatment wins government support by Lee Han-soo 2019-03-08 16:57
Gilead, Yuhan to co-promote Biktarvy by Lee Han-soo 2019-03-08 15:32
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy by Lee Han-soo 2019-03-08 14:38
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit by Lee Han-soo 2019-03-07 16:22
Daewoong marks record-high sales in 2018 by Lee Han-soo 2019-03-07 16:01
When will NOAC reversal agents be available in Korea? by Kim Yun-mi 2019-03-07 15:52
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned by Lee Hye-seon 2019-03-07 15:10
Amgen’s Xgeva solves adverse effect problems by Lee Han-soo 2019-03-07 14:25
‘Korean drugmakers can tap US generic market’ by Jeong Sae-im 2019-03-07 11:54
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate by Lee Han-soo 2019-03-06 14:27
Binex, Chongqing Zein to establish joint company by Lee Han-soo 2019-03-06 13:41
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin by Lee Han-soo 2019-03-05 16:22
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status by Lee Han-soo 2019-03-05 15:34
Handok to market Amicus Therapeutics’ Fabry disease treatment by Lee Han-soo 2019-03-05 15:11
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment by Lee Hye-seon 2019-03-05 15:10
Back to Top